Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2013

01-08-2013 | Epidemiology

Association between chronological change of reproductive factors and breast cancer risk defined by hormone receptor status: results from the Seoul Breast Cancer Study

Authors: Seokang Chung, Sue K. Park, Hyuna Sung, Nan Song, Wonshik Han, Dong-Young Noh, Sei-Hyun Ahn, Keun-Young Yoo, Ji-Yeob Choi, Daehee Kang

Published in: Breast Cancer Research and Treatment | Issue 3/2013

Login to get access

Abstract

Lifestyle factors have been chronologically changed into western style ones, which could result in the rapid increase of breast cancer incidence in Korea. It is plausible that reproductive factors through hormonal mechanisms are differentially related to the risk of breast cancer subtypes. We investigated the association of reproductive risk factors on breast cancer by birth year groups and also evaluated the differential associations on the hormone receptor-defined subtypes. Using the data from the Seoul Breast Cancer Study (SeBCS), a multicenter case–control study, 3,332 breast cancer patients and 3,620 control subjects were analyzed. The distribution of subtypes among cases was as follows: 61.0 % estrogen receptor (ER)-positive, 51.9 % progesterone receptor (PR)-positive, and 43.4 % both ER/PR-positive status, respectively. Polytomous logistic regression and Wald tests for heterogeneity have been used across the subtypes. The frequencies of reproductive-related risk factors including early age at menarche, nulligravid, age at first full-term pregnancy (FFTP), duration of estrogen exposure before FFTP (EEBF), less number of children, never breastfeeding, and short duration of breastfeeding has increased as women were born later in both cases and controls, respectively (p trend < 0.0001. Among breast cancer patients, either ER- or PR-positive subtypes were increased in women born in 1960s compared to women born in 1940s. Early age at menarche increased the risk of breast cancer regardless of the subtypes while nulligravid, late age at FFTP, and longer duration of EEBP were associated with hormone receptor-positive cancer risk only (p heterogeneity < 0.05), which associations were stronger among women born later. Our results suggest that the associations of age at menarche, parity, age at FFTP, and duration of EEBF with breast cancer risk were different based on the hormone receptor status and birth year groups in Korea.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lee JH, Yim SH, Won YJ, Jung KW, Son BH et al (2007) Population-based breast cancer statistics in Korea during 1993–2002: incidence, mortality, and survival. J Korean Med Sci 22(Suppl):S11–S16PubMedCrossRef Lee JH, Yim SH, Won YJ, Jung KW, Son BH et al (2007) Population-based breast cancer statistics in Korea during 1993–2002: incidence, mortality, and survival. J Korean Med Sci 22(Suppl):S11–S16PubMedCrossRef
2.
go back to reference Bray F, McCarron P, Parkin DM (2004) The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6:229–239PubMedCrossRef Bray F, McCarron P, Parkin DM (2004) The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6:229–239PubMedCrossRef
3.
go back to reference Jung KW, Park S, Kong HJ, Won YJ, Boo YK et al (2010) Cancer statistics in Korea: incidence, mortality and survival in 2006–2007. J Korean Med Sci 25:1113–1121PubMedCrossRef Jung KW, Park S, Kong HJ, Won YJ, Boo YK et al (2010) Cancer statistics in Korea: incidence, mortality and survival in 2006–2007. J Korean Med Sci 25:1113–1121PubMedCrossRef
4.
go back to reference Registry KCC (2009) Annual report of cancer statistics in Korea. Korean National Cancer Registry Registry KCC (2009) Annual report of cancer statistics in Korea. Korean National Cancer Registry
5.
go back to reference Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD et al (2011) Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 378:1461–1484PubMedCrossRef Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD et al (2011) Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 378:1461–1484PubMedCrossRef
6.
go back to reference Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP et al (2004) Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev 13:1558–1568PubMed Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP et al (2004) Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev 13:1558–1568PubMed
7.
go back to reference Lord SJ, Bernstein L, Johnson KA, Malone KE, McDonald JA et al (2008) Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control study. Cancer Epidemiol Biomarkers Prev 17:1723–1730PubMedCrossRef Lord SJ, Bernstein L, Johnson KA, Malone KE, McDonald JA et al (2008) Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control study. Cancer Epidemiol Biomarkers Prev 17:1723–1730PubMedCrossRef
8.
go back to reference Setiawan VW, Monroe KR, Wilkens LR, Kolonel LN, Pike MC et al (2009) Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study. Am J Epidemiol 169:1251–1259PubMedCrossRef Setiawan VW, Monroe KR, Wilkens LR, Kolonel LN, Pike MC et al (2009) Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study. Am J Epidemiol 169:1251–1259PubMedCrossRef
9.
go back to reference Yoo KY, Tajima K, Miura S, Takeuchi T, Hirose K et al (1997) Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case–control analysis. Am J Epidemiol 146:307–314PubMedCrossRef Yoo KY, Tajima K, Miura S, Takeuchi T, Hirose K et al (1997) Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case–control analysis. Am J Epidemiol 146:307–314PubMedCrossRef
10.
go back to reference Ma H, Bernstein L, Pike MC, Ursin G (2006) Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res 8:R43PubMedCrossRef Ma H, Bernstein L, Pike MC, Ursin G (2006) Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res 8:R43PubMedCrossRef
11.
go back to reference Ahn SH, Yoo KY (2006) Chronological changes of clinical characteristics in 31,115 new breast cancer patients among Koreans during 1996–2004. Breast Cancer Res Treat 99:209–214PubMedCrossRef Ahn SH, Yoo KY (2006) Chronological changes of clinical characteristics in 31,115 new breast cancer patients among Koreans during 1996–2004. Breast Cancer Res Treat 99:209–214PubMedCrossRef
12.
go back to reference Cho SH, Kim KD, Kim SR, Cho SH, Hwang YY (1999) Adolescent menstrual disorders: comparison between 1988 and 1998. Korean J Obstet Gynecol 42:2043–2047 Cho SH, Kim KD, Kim SR, Cho SH, Hwang YY (1999) Adolescent menstrual disorders: comparison between 1988 and 1998. Korean J Obstet Gynecol 42:2043–2047
13.
go back to reference Yoo KY, Kim Y, Park SK, Kang D (2006) Lifestyle, genetic susceptibility and future trends of breast cancer in Korea. Asian Pac J Cancer Prev 7:679–682PubMed Yoo KY, Kim Y, Park SK, Kang D (2006) Lifestyle, genetic susceptibility and future trends of breast cancer in Korea. Asian Pac J Cancer Prev 7:679–682PubMed
14.
go back to reference KIHASA (2006) Survey on the national fertility, family health and welfare KIHASA (2006) Survey on the national fertility, family health and welfare
15.
go back to reference KHIDI (2005) The Korea national health & nutrition examination survey. Nutr Surv 1:337 KHIDI (2005) The Korea national health & nutrition examination survey. Nutr Surv 1:337
16.
go back to reference Howell A, Harvie M (2008) Should lifestyle modifications be promoted to prevent breast cancer? Breast Cancer Res 10 Supple 4: S11PubMedCrossRef Howell A, Harvie M (2008) Should lifestyle modifications be promoted to prevent breast cancer? Breast Cancer Res 10 Supple 4: S11PubMedCrossRef
17.
go back to reference Kobayashi S, Sugiura H, Ando Y, Shiraki N, Yanagi T et al (2012) Reproductive history and breast cancer risk. Breast Cancer 19:302–308PubMedCrossRef Kobayashi S, Sugiura H, Ando Y, Shiraki N, Yanagi T et al (2012) Reproductive history and breast cancer risk. Breast Cancer 19:302–308PubMedCrossRef
18.
go back to reference Parsa P, Parsa B (2009) Effects of reproductive factors on risk of breast cancer: a literature review. Asian Pac J Cancer Prev 10:545–550PubMed Parsa P, Parsa B (2009) Effects of reproductive factors on risk of breast cancer: a literature review. Asian Pac J Cancer Prev 10:545–550PubMed
19.
go back to reference Pike MC, Spicer DV, Dahmoush L, Press MF (1993) Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15:17–35PubMed Pike MC, Spicer DV, Dahmoush L, Press MF (1993) Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15:17–35PubMed
20.
go back to reference Ponten J, Holmberg L, Trichopoulos D, Kallioniemi OP, Kvale G et al (1990) Biology and natural history of breast cancer. Int J Cancer Suppl 5:5–21PubMedCrossRef Ponten J, Holmberg L, Trichopoulos D, Kallioniemi OP, Kvale G et al (1990) Biology and natural history of breast cancer. Int J Cancer Suppl 5:5–21PubMedCrossRef
21.
go back to reference Choi JY, Lee KM, Park SK, Noh DY, Ahn SH et al (2005) Association of paternal age at birth and the risk of breast cancer in offspring: a case control study. BMC cancer 5:143PubMedCrossRef Choi JY, Lee KM, Park SK, Noh DY, Ahn SH et al (2005) Association of paternal age at birth and the risk of breast cancer in offspring: a case control study. BMC cancer 5:143PubMedCrossRef
22.
go back to reference Han S, Lee KM, Choi JY, Park SK, Lee JY et al (2008) CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk. Breast Cancer Res Treat 110:387–393PubMedCrossRef Han S, Lee KM, Choi JY, Park SK, Lee JY et al (2008) CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk. Breast Cancer Res Treat 110:387–393PubMedCrossRef
23.
go back to reference Kim HC, Lee JY, Sung H, Choi JY, Park SK et al (2012) A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study. Breast Cancer Res 14:R56PubMedCrossRef Kim HC, Lee JY, Sung H, Choi JY, Park SK et al (2012) A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study. Breast Cancer Res 14:R56PubMedCrossRef
24.
go back to reference Li CI, Malone KE, Daling JR (2002) Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev 11:601–607PubMed Li CI, Malone KE, Daling JR (2002) Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev 11:601–607PubMed
25.
go back to reference Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R et al (2003) Trends in breast cancer by race and ethnicity. CA Cancer J Clin 53:342–355PubMedCrossRef Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R et al (2003) Trends in breast cancer by race and ethnicity. CA Cancer J Clin 53:342–355PubMedCrossRef
26.
go back to reference Jones BA, Kasl SV, Howe CL, Lachman M, Dubrow R et al (2004) African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics. Cancer 101:1293–1301PubMedCrossRef Jones BA, Kasl SV, Howe CL, Lachman M, Dubrow R et al (2004) African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics. Cancer 101:1293–1301PubMedCrossRef
27.
go back to reference Chu KC, Anderson WF (2002) Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups. Breast Cancer Res Treat 74:199–211PubMedCrossRef Chu KC, Anderson WF (2002) Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups. Breast Cancer Res Treat 74:199–211PubMedCrossRef
28.
go back to reference Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A et al (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97:439–448PubMedCrossRef Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A et al (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97:439–448PubMedCrossRef
29.
go back to reference Britton JA, Gammon MD, Schoenberg JB, Stanford JL, Coates RJ et al (2002) Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20–44 years of age. Am J Epidemiol 156:507–516PubMedCrossRef Britton JA, Gammon MD, Schoenberg JB, Stanford JL, Coates RJ et al (2002) Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20–44 years of age. Am J Epidemiol 156:507–516PubMedCrossRef
30.
go back to reference Chu KC, Anderson WF, Fritz A, Ries LA, Brawley OW (2001) Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Cancer 92:37–45PubMedCrossRef Chu KC, Anderson WF, Fritz A, Ries LA, Brawley OW (2001) Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Cancer 92:37–45PubMedCrossRef
31.
go back to reference Hunter CP (2000) Epidemiology, stage at diagnosis, and tumor biology of breast carcinoma in multiracial and multiethnic populations. Cancer 88:1193–1202PubMedCrossRef Hunter CP (2000) Epidemiology, stage at diagnosis, and tumor biology of breast carcinoma in multiracial and multiethnic populations. Cancer 88:1193–1202PubMedCrossRef
32.
go back to reference Menes TS, Ozao J, Kim U (2007) Breast cancer and ethnicity: strong association between reproductive risk factors and estrogen receptor status in Asian patients—a retrospective study. Breast J 13:352–358PubMedCrossRef Menes TS, Ozao J, Kim U (2007) Breast cancer and ethnicity: strong association between reproductive risk factors and estrogen receptor status in Asian patients—a retrospective study. Breast J 13:352–358PubMedCrossRef
33.
go back to reference Krieger N, Chen JT, Ware JH, Kaddour A (2008) Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions. Cancer Causes Control 19:1305–1318PubMedCrossRef Krieger N, Chen JT, Ware JH, Kaddour A (2008) Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions. Cancer Causes Control 19:1305–1318PubMedCrossRef
34.
go back to reference Miller BA, Hankey BF, Thomas TL (2002) Impact of sociodemographic factors, hormone receptor status, and tumor grade on ethnic differences in tumor stage and size for breast cancer in US women. Am J Epidemiol 155:534–545PubMedCrossRef Miller BA, Hankey BF, Thomas TL (2002) Impact of sociodemographic factors, hormone receptor status, and tumor grade on ethnic differences in tumor stage and size for breast cancer in US women. Am J Epidemiol 155:534–545PubMedCrossRef
35.
go back to reference Anderson WF, Katki HA, Rosenberg PS (2011) Incidence of breast cancer in the United States: current and future trends. J Natl Cancer Inst 103:1397–1402PubMedCrossRef Anderson WF, Katki HA, Rosenberg PS (2011) Incidence of breast cancer in the United States: current and future trends. J Natl Cancer Inst 103:1397–1402PubMedCrossRef
36.
go back to reference Yamashita H, Iwase H, Toyama T, Takahashi S, Sugiura H et al (2011) Estrogen receptor-positive breast cancer in Japanese women: trends in incidence, characteristics, and prognosis. Ann Oncol 22:1318–1325PubMedCrossRef Yamashita H, Iwase H, Toyama T, Takahashi S, Sugiura H et al (2011) Estrogen receptor-positive breast cancer in Japanese women: trends in incidence, characteristics, and prognosis. Ann Oncol 22:1318–1325PubMedCrossRef
37.
go back to reference Zhang Q, Liu LY, Wang F, Mu K, Yu ZG (2012) The changes in female physical and childbearing characteristics in China and potential association with risk of breast cancer. BMC Public Health 12:368PubMedCrossRef Zhang Q, Liu LY, Wang F, Mu K, Yu ZG (2012) The changes in female physical and childbearing characteristics in China and potential association with risk of breast cancer. BMC Public Health 12:368PubMedCrossRef
38.
go back to reference Tamakoshi K, Yatsuya H, Wakai K, Suzuki S, Nishio K et al (2005) Impact of menstrual and reproductive factors on breast cancer risk in Japan: results of the JACC study. Cancer Sci 96:57–62PubMedCrossRef Tamakoshi K, Yatsuya H, Wakai K, Suzuki S, Nishio K et al (2005) Impact of menstrual and reproductive factors on breast cancer risk in Japan: results of the JACC study. Cancer Sci 96:57–62PubMedCrossRef
39.
go back to reference Russo J, Russo IH (1999) Cellular basis of breast cancer susceptibility. Oncol Res 11:169–178PubMed Russo J, Russo IH (1999) Cellular basis of breast cancer susceptibility. Oncol Res 11:169–178PubMed
40.
go back to reference Goldman MB, Hatch MC (2000) Breast cancer epidemiology, treatment, and prevention. Academic Press, San Diego Goldman MB, Hatch MC (2000) Breast cancer epidemiology, treatment, and prevention. Academic Press, San Diego
41.
go back to reference Collaborative Group on Hormonal Factors in Breast Cancer (2012) Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 13:1141–1151CrossRef Collaborative Group on Hormonal Factors in Breast Cancer (2012) Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 13:1141–1151CrossRef
42.
go back to reference Tryggvadottir L, Tulinius H, Eyfjord JE, Sigurvinsson T (2002) Breast cancer risk factors and age at diagnosis: an Icelandic cohort study. Int J Cancer 98:604–608PubMedCrossRef Tryggvadottir L, Tulinius H, Eyfjord JE, Sigurvinsson T (2002) Breast cancer risk factors and age at diagnosis: an Icelandic cohort study. Int J Cancer 98:604–608PubMedCrossRef
43.
go back to reference Gao YT, Shu XO, Dai Q, Potter JD, Brinton LA et al (2000) Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer 87:295–300PubMedCrossRef Gao YT, Shu XO, Dai Q, Potter JD, Brinton LA et al (2000) Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer 87:295–300PubMedCrossRef
44.
go back to reference Minami Y, Ohuchi N, Fukao A, Hisamichi S (1997) Risk factors for breast cancer: a case–control study of screen-detected breast cancer in Miyagi prefecture, Japan. Breast Cancer Res Treat 44:225–233PubMedCrossRef Minami Y, Ohuchi N, Fukao A, Hisamichi S (1997) Risk factors for breast cancer: a case–control study of screen-detected breast cancer in Miyagi prefecture, Japan. Breast Cancer Res Treat 44:225–233PubMedCrossRef
45.
go back to reference Ma H, Bernstein L, Ross RK, Ursin G (2006) Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case–case comparison. Breast Cancer Res 8:R39PubMedCrossRef Ma H, Bernstein L, Ross RK, Ursin G (2006) Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case–case comparison. Breast Cancer Res 8:R39PubMedCrossRef
46.
go back to reference Rosenberg LU, Einarsdottir K, Friman EI, Wedren S, Dickman PW et al (2006) Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 15:2482–2488PubMedCrossRef Rosenberg LU, Einarsdottir K, Friman EI, Wedren S, Dickman PW et al (2006) Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 15:2482–2488PubMedCrossRef
47.
go back to reference Li CI, Malone KE, Daling JR, Potter JD, Bernstein L et al (2008) Timing of menarche and first full-term birth in relation to breast cancer risk. Am J Epidemiol 167:230–239PubMedCrossRef Li CI, Malone KE, Daling JR, Potter JD, Bernstein L et al (2008) Timing of menarche and first full-term birth in relation to breast cancer risk. Am J Epidemiol 167:230–239PubMedCrossRef
48.
go back to reference Wu MH, Chou YC, Yu JC, Yu CP, Wu CC et al (2006) Hormonal and body-size factors in relation to breast cancer risk: a prospective study of 11,889 women in a low-incidence area. Ann Epidemiol 16:223–229PubMedCrossRef Wu MH, Chou YC, Yu JC, Yu CP, Wu CC et al (2006) Hormonal and body-size factors in relation to breast cancer risk: a prospective study of 11,889 women in a low-incidence area. Ann Epidemiol 16:223–229PubMedCrossRef
49.
go back to reference Colditz GA, Frazier AL (1995) Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomarkers Prev 4:567–571PubMed Colditz GA, Frazier AL (1995) Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomarkers Prev 4:567–571PubMed
50.
go back to reference Madigan MP, Troisi R, Potischman N, Dorgan JF, Brinton LA et al (1998) Serum hormone levels in relation to reproductive and lifestyle factors in postmenopausal women (United States). Cancer Causes Control 9:199–207PubMedCrossRef Madigan MP, Troisi R, Potischman N, Dorgan JF, Brinton LA et al (1998) Serum hormone levels in relation to reproductive and lifestyle factors in postmenopausal women (United States). Cancer Causes Control 9:199–207PubMedCrossRef
51.
go back to reference Bernstein L, Pike MC, Ross RK, Judd HL, Brown JB et al (1985) Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst 74:741–745PubMed Bernstein L, Pike MC, Ross RK, Judd HL, Brown JB et al (1985) Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst 74:741–745PubMed
52.
go back to reference Garcia-Closas M, Herbstman J, Schiffman M, Glass A, Dorgan JF (2002) Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphisms in pre-menopausal women. Int J Cancer 102:172–178PubMedCrossRef Garcia-Closas M, Herbstman J, Schiffman M, Glass A, Dorgan JF (2002) Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphisms in pre-menopausal women. Int J Cancer 102:172–178PubMedCrossRef
53.
go back to reference Dorgan JF, Reichman ME, Judd JT, Brown C, Longcope C et al (1995) Relationships of age and reproductive characteristics with plasma estrogens and androgens in premenopausal women. Cancer Epidemiol Biomarkers Prev 4:381–386PubMed Dorgan JF, Reichman ME, Judd JT, Brown C, Longcope C et al (1995) Relationships of age and reproductive characteristics with plasma estrogens and androgens in premenopausal women. Cancer Epidemiol Biomarkers Prev 4:381–386PubMed
54.
go back to reference Apter D, Reinila M, Vihko R (1989) Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood. Int J Cancer 44:783–787PubMedCrossRef Apter D, Reinila M, Vihko R (1989) Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood. Int J Cancer 44:783–787PubMedCrossRef
55.
go back to reference Kelsey JL, Gammon MD, John EM (1993) Reproductive factors and breast cancer. Epidemiol Rev 15:36–47PubMed Kelsey JL, Gammon MD, John EM (1993) Reproductive factors and breast cancer. Epidemiol Rev 15:36–47PubMed
56.
go back to reference Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE (2004) Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 96:1856–1865PubMedCrossRef Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE (2004) Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 96:1856–1865PubMedCrossRef
57.
go back to reference Sieri S, Krogh V, Bolelli G, Abagnato CA, Grioni S et al (2009) Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev 18:169–176PubMedCrossRef Sieri S, Krogh V, Bolelli G, Abagnato CA, Grioni S et al (2009) Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev 18:169–176PubMedCrossRef
58.
go back to reference Ko BS, Noh WC, Kang SS, Park BW, Kang EY et al (2012) Changing patterns in the clinical characteristics of Korean breast cancer from 1996–2010 using an online nationwide breast cancer database. J Breast Cancer 15:393–400PubMedCrossRef Ko BS, Noh WC, Kang SS, Park BW, Kang EY et al (2012) Changing patterns in the clinical characteristics of Korean breast cancer from 1996–2010 using an online nationwide breast cancer database. J Breast Cancer 15:393–400PubMedCrossRef
59.
go back to reference Bao PP, Shu XO, Gao YT, Zheng Y, Cai H et al (2011) Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study. Am J Epidemiol 174:661–671PubMedCrossRef Bao PP, Shu XO, Gao YT, Zheng Y, Cai H et al (2011) Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study. Am J Epidemiol 174:661–671PubMedCrossRef
60.
go back to reference Kim Y, Jun JK, Choi KS, Lee HY, Park EC (2011) Overview of the National Cancer screening programme and the cancer screening status in Korea. Asian Pac J Cancer Prev 12:725–730PubMed Kim Y, Jun JK, Choi KS, Lee HY, Park EC (2011) Overview of the National Cancer screening programme and the cancer screening status in Korea. Asian Pac J Cancer Prev 12:725–730PubMed
61.
go back to reference Na HK, Oliynyk S (2011) Effects of physical activity on cancer prevention. Ann N Y Acad Sci 1229:176–183PubMedCrossRef Na HK, Oliynyk S (2011) Effects of physical activity on cancer prevention. Ann N Y Acad Sci 1229:176–183PubMedCrossRef
62.
go back to reference Kushi LH, Byers T, Doyle C, Bandera EV, McCullough M, et al. (2006) American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 56: 254–281; quiz 313–254 Kushi LH, Byers T, Doyle C, Bandera EV, McCullough M, et al. (2006) American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 56: 254–281; quiz 313–254
63.
go back to reference Arpino G, Bardou VJ, Clark GM, Elledge RM (2004) Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 6:R149–R156PubMedCrossRef Arpino G, Bardou VJ, Clark GM, Elledge RM (2004) Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 6:R149–R156PubMedCrossRef
Metadata
Title
Association between chronological change of reproductive factors and breast cancer risk defined by hormone receptor status: results from the Seoul Breast Cancer Study
Authors
Seokang Chung
Sue K. Park
Hyuna Sung
Nan Song
Wonshik Han
Dong-Young Noh
Sei-Hyun Ahn
Keun-Young Yoo
Ji-Yeob Choi
Daehee Kang
Publication date
01-08-2013
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2013
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-013-2645-4

Other articles of this Issue 3/2013

Breast Cancer Research and Treatment 3/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine